
Global Superdisintegrants Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
-
8422
-
Upcoming
-
NA
-
PDF
-
find_in_page Our Research Methodology is based on the following main points:
- Data Collections and Interpretation
- Analysis
- Data Validation
- Final Projections and Conclusion
- notifications
-
"Global Superdisintegrants Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global superdisintegrants market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global superdisintegrants market report has been segmented on the basis of form, application, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the global market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the global superdisintegrants market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Overview:
Superdisintegrants is act as a medium in drug formulation that helps to the disintegration or dissolution of any tablet or capsule content at a rapid speed. Superdisintegrants is a chemically modified disintegrants that improves the disintegration processes and provides high dissolution rate.
Dynamics:
Increasing preference for active molecules for various healthcare treatment across the globe is a key factor expected to drive growth of the global superdisintegrants market during the forecast period, owing to benefits offered by superdisintegrants such as, capacity to carry active molecules in their pure form and ability to provide accurate dosage of drugs.
In addition, increasing preference for disintegrants from various drug manufacturers is expected to support growth of the global superdisintegrants market, owing to various features of superdisintegrants such as, improved compressibility, compatibility, and reduced adverse impact on formulations containing high-dose drugs.
Growing demand for fast dissolution formulation of medicines among patients across the globe is expected to proliferate growth of the global superdisintegrants market, owing to benefit offered by superdisintegrants such as, high wet granulation and high-shear in granulation processes in case of solid dosage forms.
Furthermore, increasing preference for orally disintegrating tablet (ODT) product among patients across the globe is expected to generate significant opportunities for prominent players in healthcare sector.
However, rising concerns associated with drug safety and quality, and increasing stringent healthcare regulations by healthcare authorities for various drugs formulations across the globe are some factors expected to hamper growth of target market to a certain extent.
Regional Analysis:
Market in North America is expected to dominate the global market in terms of revenue followed by Europe, owing to increasing innovation and development of superdisintegrants in the development of various oral drugs with active molecules among healthcare sector in countries in the region. In addition, presence of leading pharmaceutical manufacturers with large and advance production capacities and high awareness about characteristics of superdisintegrants is expected to boost growth of the global market in countries in the North America and Europe region.
Market in Asia Pacific is expected to witness lucrative growth of the global market in terms of revenue, owing to increasing preference for orally disintegrating tablet (ODT) among patients from emerging countries such as China, India, and Japan. In addition, Asia Pacific region is expected to be largest consumer of orally disintegrating tablet (ODT) products in the near future, owing to increasing utilization of disintegrants among pharmaceutical industries to achieve high dissolution rate for various oral drugs. In addition, high presence of generic drug manufacturers among emerging countries such as, India and China is a key factor expected to support high utilization of superdisintegrants for various drug development.
Global Market Segmentation:
Global market segmentation, by product type:
- Natural Superdisintegrants
- Synthetic Superdisintegrants
- Modified Starch
- Modified Cellulose
- Croscarmellose- Cellulose
- Low-substituted Hydroxypropyl Cellulose (L-HPC)
- Other Synthetic Superdisintegrants (Crospovidone, Ion Exchange Resins, and Calcium Silicates)
- Modified Starch
Global market segmentation, by formulation:
- Tablets
- Capsules
Global market segmentation, by therapeutic area:
- Oncology
- Infectious Diseases
- Neurological Diseases
- Inflammatory Diseases
- Cardiovascular Diseases
- Hematological Diseases
- Gastrointestinal Diseases
Global market segmentation, by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region - North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$ -
- BASF SE
- DFE Pharma
- Dowdupont, Inc.
- Roquette Freres S.A.
- JRS Pharma Gmbh & Co.
- Asahi Kasei Corporation
- Corel Pharma Chem
- Huber Corporation
- Ashland Global Holdings Inc.
- Merck Kommanditgesellschaft auf Aktien company (KGaA)
-
Request for TOC
-
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!